Dementia News and Research

Latest Dementia News and Research

GSK, ProteoTech enter R&D agreement to develop new Parkinson's therapeutics

ProteoTech, Inc., a privately held biotechnology company, has entered into a drug development agreement with GlaxoSmithKline (China) R&D Company Limited (GSK) to collaborate on ProteoTech's small molecule technology platform against misfolded proteins to specifically advance work on its alpha-synuclein therapeutic program for the treatment of Parkinson's disease and other synucleinopathies.

21 Dec 2011

Dieting and the youth of the brain may be linked: Study

Italian scientists have found that the mind can be kept young by eating less. They have discovered the molecular process by which a strict diet may save the brain from the ravages of age.

20 Dec 2011

Cognitive function may be a better indicator of impact of aging on an economy

Cognitive function may be a better indicator of the impact of aging on an economy than age-distribution, with chronological age imposing less of a social and economic burden if the population is "functionally" younger, according to a study published today in the Proceedings of the National Academy of Sciences.

20 Dec 2011

UCL awarded 20M grant to establish The Leonard Wolfson Experimental Neurology Centre

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.

19 Dec 2011

UCL to establish new center for treatment of neurodegenerative diseases

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a £20million grant from the Wolfson Foundation, it was announced today.

19 Dec 2011

SIRT1 gene appears to delay onset of HD in mouse model

Working with genetically engineered mice, Johns Hopkins researchers have discovered that a gene (SIRT1) linked to slowing the aging process in cells also appears to dramatically delay the onset of Huntington's disease (HD) and slow the progression of the relentless neurodegenerative disorder.

19 Dec 2011

2012 to open up opportunities in booming Australian home care industry

Spending on home care services could grow to up to $11 billion per year if industry deregulation plans are adopted by the Federal Government, according to a forecast from one of the country’s leading home care providers.

18 Dec 2011

Experts argue about dementia detection in primary care practice at AFA-ADDF meeting

Many people with dementia don't realize they have the disease until it's at an advanced stage, when everyone can tell something is wrong. Other people might start forgetting dates or names and worry they have dementia, yet their memory problems are just a normal consequence of aging.

17 Dec 2011

GE Healthcare's MIND campaign goes online for patients with neurodegenerative diseases

GE Healthcare's MIND campaign is going online to give those affected by neurodegenerative diseases like Alzheimer's or other forms of dementia and parkinsonian syndromes a platform to share their stories.

17 Dec 2011

Decision support tool for objective diagnostics of Alzheimer's

European PredictAD project, lead by Principal Scientist Jyrki Lötjönen from VTT Technical Research Centre of Finland, has developed a decision support tool for objective diagnostics of Alzheimer's disease.

15 Dec 2011

AtheroNova establishes clear development plan for AHRO-001 after positive FDA feedback

AtheroNova Inc., a biotech company focused on the research and development of compounds to regress atherosclerotic plaque has established a clear development plan, including Phase I and Phase II protocol outlines, based on the recently finalized minutes of its pre-IND meeting with the U.S. Food and Drug Administration (FDA) for its AHRO-001, a compound for the treatment of atherosclerosis.

15 Dec 2011

Molecular signature indicative of hypoxia predicts progression to AD

A study led by Research Professor Matej Ore-ič from VTT Technical Research Centre of Finland suggests that Alzheimer's disease is preceded by a molecular signature indicative of hypoxia and up-regulated pentose phosphate pathway.

15 Dec 2011

Acetylcholine can weaken synaptic connections between neurons in brain

Researchers from the University of Bristol have discovered that a chemical compound in the brain can weaken the synaptic connections between neurons in a region of the brain important for the formation of long-term memories.

14 Dec 2011

Link between high tau levels and worse outcome after head trauma

High levels of tau protein in fluid bathing the brain are linked to poor recovery after head trauma, according to a study from Washington University School of Medicine in St. Louis and the Fondazione IRCCS Ca Granda-Ospedale Maggiore Policlinico in Milan, Italy.

14 Dec 2011

Brain atrophy is evident in Parkinson's patients with MCI

Atrophy in the hippocampus, the region of the brain known for memory formation and storage, is evident in Parkinson's disease (PD) patients with cognitive impairment, including early decline known as mild cognitive impairment (MCI), according to a study by researchers in the Perelman School of Medicine at the University of Pennsylvania.

13 Dec 2011

Intertwined diseases may both contribute to cognitive decline in Parkinson's

A method of classifying brain atrophy patterns in Alzheimer's disease patients using MRIs can also detect cognitive decline in Parkinson's disease, according to a new study by researchers from the Perelman School of Medicine at the University of Pennsylvania. Researchers also found that higher baseline Alzheimer's patterns of atrophy predicted long-term cognitive decline in cognitively normal Parkinson's patients.

13 Dec 2011

Alzheimer’s disease vaccine developed by Australian scientists

Scientists from the University of Sydney on Saturday have announced that they have developed a vaccine to help halt the progression of Alzheimer's disease of humans. The progress of neurodegenerative condition affects more than 35 million people worldwide.

12 Dec 2011

Tips to help ease caregiver's burden during holiday season

More five million Americans suffer from Alzheimer's disease or another form of dementia and over 70 percent of those individuals are cared for in their homes by a spouse or other family member. Stress, anxiety and burnout are never far from the doorsteps of these caregivers as they often juggle the responsibilities of providing daily care with the added demands of working, maintaining a household, or raising children. The holiday season can intensify these daily burdens, but too often caregivers don't know how to ask for help and friends and family members aren't sure of how to lend a hand.

9 Dec 2011

Ovary removal in younger women may lead to low-bone mineral density, arthritis

Having both ovaries removed before age 45 is strongly associated with low-bone mineral density and arthritis in later years, according to a new study by Johns Hopkins oncologists and epidemiologists. The analysis covered several thousand women who took part in a U.S. government-sponsored, multiyear national health study, and excluded women whose ovaries were removed due to cancer.

9 Dec 2011

Pharmacyclics, Janssen partner to develop and market PCI-32765 anti-cancer compound

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed an agreement with Pharmacyclics, Inc. to jointly develop and market the anti-cancer compound, PCI-32765.

9 Dec 2011